Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
TLIS holding history
Talis Biomedical Corp in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TLIS overviewAll 13F holders of TLISFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −10,024−100.0% | Sold out | Holders |
| Q4 2023 | 10,024 | $74.7K | <0.1% | +10,024 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −2,592−100.0% | Sold outConverted for a 1-for-15 split | Holders |
| Q2 2023 | 38,876 | $18.7K | <0.1% | +38,876 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −95,060−100.0% | Sold out | Holders |
| Q4 2022 | 95,060 | $42.3K | <0.1% | +95,060 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −42,242−100.0% | Sold out | Holders |
| Q2 2022 | 42,242 | $34.0K | <0.1% | +42,242 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −34,707−100.0% | Sold out | Holders |
| Q4 2021 | 34,707 | $139.0K | <0.1% | +8,561+32.7% | Added | Holders |
| Q3 2021 | 26,146 | $163.0K | <0.1% | +26,146 | New | Holders |